Sharma Vivek

Insider profile

Performance

Overall performance
2.3
Performance over holding periods
2.3
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Sharma Vivek's trades of Symbiotec Pharmalab Limited's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
115.74
Quantity 22,965
Value ₹1,955,928
Transaction date
Sale
Price
1,054.78
Quantity 5,500
Value ₹5,801,301
Transaction date
Purchase
Price
483.00
Quantity 2,400,000
Value ₹1,159,200,000
Transaction date
Sale
Price
5.42
Quantity 585 -1.6%
Value US$3,168
Transaction date
Sale
Price
5.41
Quantity 26,415 -42.3%
Value US$142,905
Transaction date
Sale
Price
5.40
Quantity 5,000 -7.4%
Value US$27,000
Transaction date
Proposed sale
Price
5.41
Quantity 32,000
Value US$173,073
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-05 2026-09-30
S Sale
40,655
107.36
₹3,627,383 		40,655 107.36 ₹3,627,383
2026-10-05 2026-09-30
S Sale
61,435
75.90
₹2,805,419 		61,435 75.90 ₹2,805,419
2026-10-05 2026-09-29
S Sale
22,965
115.74
₹1,955,928 		22,965 115.74 ₹1,955,928
2026-10-05 2026-09-28
S Sale
5,500
1,054.78
₹5,801,301 		5,500 1,054.78 ₹5,801,301
2026-06-06 2026-06-03
B Purchase
2,400,000
483.00
₹1,159,200,000 		2,400,000 483.00 ₹1,159,200,000
2026-06-01 2026-05-28
S Sale
585 -1.6%
5.42
US$3,168 		585 -1.6% 5.42 US$3,168
2026-06-01 2026-05-28
S Sale
26,415 -42.3%
5.41
US$142,905 		26,415 -42.3% 5.41 US$142,905
2026-06-01 2026-05-28
S Sale
5,000 -7.4%
5.40
US$27,000 		5,000 -7.4% 5.40 US$27,000
2026-05-28 2026-05-28
PrS Proposed sale
32,000
5.41
US$173,073 		32,000 5.41 US$173,073